Consensus Abbott Laboratories Kazakhstan S.E.

Stocks

ABT_KZ

US0028241000

Medical Equipment, Supplies & Distribution

End-of-day quote Kazakhstan S.E. 18/09/2026			5-day change	1st Jan Change
105.00 ^USD	-3.67%		-4.55%	-27.08%

09-18	Trinity Heart Experts First in the Quad Cities to Use New Afib Technology	CI
09-17	Abbott Laboratories Declares Quarterly Dividend, Payable on Nov. 16, 2026	CI

9f32363916b9e40cc.UEawOQFS24yS9NuPoiMHwNZ03Qwr342LJsNdqrFvLT0.Gwn0CHsZkM_8vJL6zHZtpp1EizVTjsrYXO4Q4IYIRHIqIehxMWO56ui9lg~081abaf24566ba581df35f5ff9964a8f

Analysts' recommendations: Abbott Laboratories

08-21	TD Cowen Adjusts Price Target on Abbott Laboratories to $135 From $115, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on Abbott Laboratories to $125 From $112, Maintains Buy Rating	MT
08-13	Wolfe Research Upgrades Abbott Laboratories to Outperform From Peer Perform, PT is $130	MT
07-28	UBS Adjusts Price Target on Abbott Laboratories to $125 From $135, Maintains Buy Rating	MT
07-28	Rothschild & Co Redburn Adjusts PT on Abbott Laboratories to $119 From $126, Maintains Neutral Rating	MT
07-23	Daiwa Securities Adjusts Price Target on Abbott Laboratories to $103 From $92, Maintains Neutral Rating	MT
07-22	Leerink Partners Adjusts Price Target on Abbott Laboratories to $109 From $106, Maintains Market Perform Rating	MT
07-17	Abbott Laboratories Seen on Track for H2 Growth Acceleration, RBC Says	MT
07-17	JPMorgan Adjusts Price Target on Abbott Laboratories to $120 From $110, Maintains Overweight Rating	MT
07-17	Piper Sandler Adjusts Price Target on Abbott Laboratories to $118 From $115, Maintains Overweight Rating	MT
07-17	BTIG Adjusts Price Target on Abbott Laboratories to $134 From $131, Maintains Buy Rating	MT
07-17	Citigroup Adjusts Price Target on Abbott Laboratories to $112 From $108, Maintains Buy Rating	MT
07-17	Bernstein Adjusts Price Target on Abbott Laboratories to $117 From $110, Maintains Outperform Rating	MT
07-17	Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $112, Maintains Outperform Rating	MT
07-16	Wells Fargo Raises Abbott Laboratories Price Target to $112 From $109	MT
07-06	Evercore ISI Adjusts Abbott Laboratories Price Target to $112 From $120	MT
07-01	Baird Initiates Abbott Laboratories at Outperform With $121 Price Target	MT
06-12	BofA Adjusts Price Target on Abbott Laboratories to $102 From $120	MT
05-27	Goldman Sachs Adjusts Price Target on Abbott Laboratories to $113 From $121, Maintains Buy Rating	MT
05-05	Abbott Laboratories Pick of the Week at Smart Insider Following CFO Stock Purchase	MT
04-22	Analyst recommendations: Albemarle, Biogen, Qualcomm, Twilio, Lyondellbasell…
04-22	Daiwa Downgrades Abbott Laboratories to Neutral From Outperform, Adjusts PT to $92 From $113	MT
04-21	Leerink Partners Adjusts PT on Abbott Laboratories to $106 From $119, Maintains Market Perform Rating	MT
04-21	Argus Adjusts Price Target on Abbott Laboratories to $125 From $140, Maintains Buy Rating	MT
04-20	Argus Cuts Abbott Laboratories' Price Target to $125 From $140	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
ABBOTT LABORATORIES	-	-	-	-
ABBOTT LABORATORIES				+17.2%
MEDTRONIC PLC				+13.79%
CENCORA, INC.				+19.6%
BECTON, DICKINSON AND COMPANY				+8.14%
HOYA CORPORATION				+33.6%
DEXCOM, INC.				+5.74%
MEDLINE INC.				+40.96%
WEST PHARMACEUTICAL SERVICES, INC.				+11.89%
SARTORIUS STEDIM BIOTECH				+18.88%
Average				+18.87%
Weighted average by Cap.				+17.66%